Welcome to our dedicated page for Greenland Acquisition SEC filings (Ticker: GLACU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sorting through Global Lights Acquisition Corp’s dense SPAC paperwork can feel like decoding a prospectus in another language. Trust-fund balances shift, extension deadlines approach, and a single 8-K can determine whether redemptions rise or fall. If you have ever searched "Global Lights Acquisition Corp insider trading Form 4 transactions" or wondered how an 8-K on a potential merger affects dilution, you know the challenge.
Stock Titan’s AI-powered analysis removes that friction. We translate every Global Lights Acquisition Corp quarterly earnings report 10-Q filing and annual report 10-K simplified into clear summaries, flagging cash held in trust, deferred underwriting fees, and sustainability criteria the sponsor must meet. Real-time alerts surface each Global Lights Acquisition Corp Form 4 insider transactions in seconds, so you can monitor executive stock movements before they hit the headlines. Our coverage spans every disclosure type—proxies for extension votes, S-1 amendments, and "Global Lights Acquisition Corp 8-K material events explained"—all streamed the moment EDGAR posts.
Use these insights to:
- Track redemption risk ahead of combination votes
- Compare sponsor warrant structures across filings
- Understand how proposed ESG targets may shift valuation
Karpus Management, Inc. filed Amendment No. 2 to Schedule 13G for Eureka Acquisition Corp (EURKU) covering the event date 30 June 2025.
The registered investment adviser now reports beneficial ownership of 327,400 common shares, representing 4.28 % of the outstanding class. Karpus holds sole voting and dispositive power over the entire position and no shared power with other parties. Because the stake has fallen below the 5 % threshold, Karpus is no longer deemed a 5 % beneficial owner under Section 13(d) of the Exchange Act but remains subject to Rule 13d-1(b) reporting requirements.
The shares are held in discretionary advisory accounts managed by Karpus, which operates independently of its parent, City of London Investment Group plc, through established informational barriers. The filing affirms that the securities were acquired in the ordinary course of business and not for the purpose of influencing control of the issuer.
Implications for investors: the reduction slightly increases EURKU’s public float and removes Karpus from the list of significant 5 % holders, potentially diminishing expectations of activist involvement. Nonetheless, a 4.28 % position remains a meaningful minority interest that could provide ongoing institutional oversight.
Core Scientific, Inc. (Nasdaq: CORZ) filed an Item 7.01 Form 8-K disclosing that it has entered into an Agreement and Plan of Merger whereby CoreWeave, Inc. will acquire Core Scientific in an all-stock transaction dated 7 July 2025. The joint press release (Ex. 99.1) is furnished, not filed, meaning it is exempt from Exchange Act Section 18 liability and will not be incorporated into other SEC filings unless expressly referenced.
The filing contains no financial terms such as exchange ratio, implied valuation or expected closing date, but it confirms that:
- The deal is subject to customary conditions, including Core Scientific stockholder approval and required regulatory clearances.
- CoreWeave will register the shares it issues on Form S-4; Core Scientific will distribute a proxy statement/prospectus to its shareholders.
- Both companies caution that forward-looking statements are subject to numerous risks, including integration challenges, regulatory delays, market volatility in AI, power, data-center and crypto-mining sectors, and potential litigation.
The company highlights multiple avenues for obtaining additional information—SEC EDGAR, both companies’ IR websites—and reiterates that no offer or solicitation is being made by this communication. Exhibit 104 provides iXBRL cover-page data.
Investment perspective: A proposed all-stock acquisition is typically neutral-to-positive for the target’s equity holders because it can crystallize strategic value and provide ownership in a larger combined entity, but the absence of pricing, conversion ratio and timeline leaves material uncertainty. Shareholders should monitor subsequent S-4 filings for definitive terms.